Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 May-Jun;19(3):317-31.
doi: 10.4103/2230-8210.152762.

Forum for Injection Technique (FIT), India: The Indian recommendations 2.0, for best practice in Insulin Injection Technique, 2015

Nikhil Tandon  1 , Sanjay Kalra  2 , Yatan Pal Singh Balhara  3 , Manash P Baruah  4 , Manoj Chadha  5 , Hemraj B Chandalia  6 , Subhankar Chowdhury  7 , Kesavadev Jothydev  8 , Prasanna K M Kumar  9 , Madhu S V  10 , Ambrish Mithal  11 , Sonal Modi  12 , Shailesh Pitale  13 , Rakesh Sahay  14 , Rishi Shukla  15 , Annamalai Sundaram  16 , Ambika G Unnikrishnan  17 , Subhash K Wangnoo  18
Affiliations
Review

Forum for Injection Technique (FIT), India: The Indian recommendations 2.0, for best practice in Insulin Injection Technique, 2015

Nikhil Tandon et al. Indian J Endocrinol Metab. 2015 May-Jun.

Abstract

As injectable therapies such as human insulin, insulin analogs, and glucagon-like peptide-1 receptor agonists are used to manage diabetes, correct injection technique is vital for the achievement of glycemic control. The forum for injection technique India acknowledged this need for the first time in India and worked to develop evidence-based recommendations on insulin injection technique, to assist healthcare practitioners in their clinical practice.

Keywords: Adherence; aspart; degludec; detemir; diabetes; education; glargine; glucagon-like peptide 1 receptor agonists; glulisine; injection sites; injection technique; injections; insulin; insulin analogs; lipohypertrophy; lispro; needle length; skin-fold; storage.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: No.

Figures

Figure 1
Figure 1
Grading criteria (Frid et al., 2010)
See this image and copyright information in PMC

References

    1. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007;125:217–30. - PubMed
    1. The IDF Atlas. 2014. Dec, [Last accessed on 2014 Dec 15]. Available from: http://www.idf.org/sites/default/files/DA-regional-factsheets-2014_FINAL... .
    1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4–14. - PubMed
    1. Crasto W, Jarvis J, Khunti K, Davies MJ. New insulins and new insulin regimens: A review of their role in improving glycaemic control in patients with diabetes. Postgrad Med J. 2009;85:257–67. - PubMed
    1. Prasad R. Innovate for diabetes in India. [Last accessed on 2014 Dec 15]. Available from: http://www.blogs. novonordisk.com/graduates/2010/10/27/innovate-for-diab...